Canadian Journal of Gastroenterology and Hepatology / 2018 / Article / Tab 4

Research Article

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Table 4

Baseline levels of fasting glycemia and impaired fasting glucose or type 2 diabetes mellitus prevalence according to treatment experience.

Absolute (relative) 
counts or mean±SEM
Treatment experienced 
Absolute (relative) 
counts or mean±SEM

All patients

Glycemia (mmol/L)5.71±0.156.41±0.160.006

IFG19 (17.1)74 (28.6)0.008

T2DM23 (20.7)65 (25.1)0.411

IFG or T2DM42 (37.8)139 (53.7)0.005

Only F4 fibrosis patients

Glycemia (mmol/L)6.16±0.236.86±0.260.637

IFG10 (23.3)36 (28.3)0.535

T2DM13 (30.2)41 (32.3)0.921

IFG or T2DM23 (53.5)77 (60.6)0.411

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.